Robert G. Gish, MD, and the Global Liver Institute join up for a talk on all things hepatology.
Approximately 4% of all people in the world will die from either cirrhosis or liver cancer. Another 25% in the US will abuse alcohol on at least 1 day annually. And yet, fewer than 10% of those who need a liver transplant will receive an organ.
Liver disease is not always the biggest, scariest burden on public health—but it is always among them. From a rising prevalence of liver cancer to unanswered questions surrounding hepatitis C eradication efforts, hepatology is a critical field in modern medicine. Its biggest issues merit discussion.
In this week’s #DocTalk Tweet Chat, Robert G. Gish, MD, Adjunct Professor of Medicine at the University of Nevada School of Medicine in Las Vegas and Medical Director of the Hepatitis B Foundation, joins MD Magazine® to lead a discussion on “The State of Liver Disease.”
#DocTalk is a weekly conversation featured on Twitter that focuses on the biggest issues in healthcare today. Join us Wednesday, August 14, at 4 PM EST for the start of our chat, featuring co-host Robert G. Gish, MD, and the Global Liver Institute (@GlobalLiver).
Gish, a major investigator and policy influencer in the space of hepatologic treatment, will lead discussion on the following questions and topics:
We invite all interested Twitter users to participate in the chat and contribute their own perspective and questions.
Be sure to search for “#DocTalk,” follow MD Mag on Twitter (@MDMagazine), and look for the social media icon signifying the chat:
If you’re a frequent Twitter user with a background in healthcare and interest in leading a #DocTalk chat with your colleagues, contact us here.